Single enzyme provides target for new sepsis drugs
Researchers have discovered that removing the enzyme, PHLPP1, improves outcomes in a mouse model of sepsis so could be a potential drug target.
List view / Grid view
Researchers have discovered that removing the enzyme, PHLPP1, improves outcomes in a mouse model of sepsis so could be a potential drug target.
It has been discovered that Polo-like kinase (PLK1) guards against severe DNA damage and could help target fast-growing cancer cells.
New study shows that a subset of follicular helper T cells contributes to the hyposialylation of autoantibodies in rheumatoid arthritis.
Researchers have newly found that protein CD24 acts as a defensive signal and is used by cancer cells to protect themselves.
A new study has shown that proteins derived from the oncogene, KRAS, can transfer between colon cancer cells.
Immunohistochemistry (IHC) and immunocytochemistry (ICC) are techniques employed to localize antigen expression and are dependent on specific epitope-antibody interactions.
The advent of in vitro culturing of neural cells has been central to driving our understanding of the nervous system.
Scientists have shown that an omega-6 polyunsaturated fatty acid could halt the progression of atherosclerosis, a leading cause of heart disease.
New study shows the ability of CD8+ cytotoxic T cells to penetrate a large target, which opens avenues to destroy solid cancers.
Researchers have used machine learning to discover that the two most widespread DNA structures cause genome mutations that lead to cancer.
Research from Oregon Health & Science University could lead to new therapies to heal nervous system disorders.
Stem cell stimulation shows promise as a potential noninvasive stroke treatment.
A new 'optochemogenetics' research approach from scientists at the Emory University School of Medicine could aid in helping stroke victims.
A new study has identified antibodies that may hold the key to creating the first effective vaccine against malaria infection in the blood.
Researchers have, for the first time, duplicated a patient's blood-brain barrier (BBB), creating a human BBB chip with stem cells.